Active Ingredient History
Omalizumab, sold under the brand name Xolair, is an injectable medication to treat severe persistent allergic forms of asthma, nasal polyps, urticaria (hives), and immunoglobulin E-mediated food allergy. Wikipedia
Drug Pricing (per unit)
Note: This drug pricing data is preliminary, incomplete, and may contain errors.
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Allergy and Immunology (Phase 3)
Anaphylaxis (Phase 2)
Angioedema (Phase 4)
Aspergillosis, Allergic Bronchopulmonary (Phase 4)
Aspirin (Phase 4)
Asthma ()
Autism Spectrum Disorder (Phase 1)
Bronchial Spasm (Phase 2)
Bronchitis (Phase 2/Phase 3)
Child (Phase 4)
Chronic Urticaria (Phase 4)
Colonic Neoplasms (Phase 1)
COVID-19 (Phase 2)
Cystic Fibrosis (Phase 4)
Cystitis, Interstitial (Phase 3)
Dermatitis, Atopic (Phase 4)
Drug Hypersensitivity (Phase 1)
Eosinophilic Esophagitis (Phase 1)
Esophagitis (Phase 2)
Food Hypersensitivity (Phase 4)
Gastroenteritis (Phase 2)
Healthy Volunteers (Phase 1)
Hypersensitivity (Phase 4)
Hypotension (Phase 2)
Immune System Diseases (Phase 1)
Immunotherapy (Phase 2)
Infertility, Female (Phase 2)
Job Syndrome (Phase 1)
Lung Diseases (Phase 4)
Lupus Erythematosus, Systemic (Phase 1)
Mastocytosis (Phase 2/Phase 3)
Milk Hypersensitivity (Phase 2)
Nasal Polyps (Phase 4)
Nephritis (Phase 2)
Omalizumab (Phase 2)
Peanut Hypersensitivity (Phase 3)
Pemphigoid, Bullous (Phase 4)
Pharmacokinetics (Phase 1)
Physiological Effects of Drugs (Phase 2)
Pulmonary Disease, Chronic Obstructive (Phase 2)
Rhinitis (Phase 2)
Rhinitis, Allergic (Phase 4)
Rhinitis, Allergic, Seasonal (Phase 3)
Signs and Symptoms (Phase 2)
Sinusitis (Phase 4)
Sjogren's Syndrome (Phase 1)
Urticaria ()
Virus Diseases (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue